/ Press Release Details /

Critical Care Diagnostics Market Size Worth USD 1.39 Billion by 2025 | CAGR: 3.9%

The Critical Care Diagnostics market is expected to grow at CAGR of 3.9% to reach USD 1.39 billion by 2025.

Critical care diagnostics is an important wing of the medical science industry. It includes a set of procedures that are carried out on patients to diagnose life threatening diseases. Critical care diagnostics helps in providing quick and reliable diagnosis to the doctors. Critical care diagnostics include invasive and normal procedures like lifesaving monitoring methods.

Countries like China and India have the youngest population currently. Thus, the need of the critical care diagnostics will only increase after every passing year as the population grows older. The data of the United Nations was also backed by this. It says that by 2050, one in six human being will be above the age of 60. At the same time, even telehealth services are growing in remote areas. This will also promote the growth of the critical care diagnostics. The only restraint of this industry is that these procedures are very expensive and there is a shortage of skilled labour to carry them out.

Browse 64 Tables and 124 Figures spread through over 150 Pages and in-depth TOC on “Critical Care Diagnostics Market, by Type (Flow Cytometry, Routine & Special Chemistry, Immuno-proteins, Hematology, Coagulation Testing, and Microbial & Infectious Disease), By End-User (Intensive Care Units, Operation Room, and Emergency Room) and Geography– Analysis, Share, Trends, Size, & Forecast from 2014 – 2025”

Request Sample Here

Key Takeaways

There are various categories under critical care diagnostics which include haematology, infectious disease, microbial, flow cytometry, immune proteins, coagulation testing and others. Immune proteins dominate this industry given the early demand of the diagnostic tools that are used by these products.
Critical care diagnostics provide early diagnosis methods. This results in quicker treatment and it also saves the recovery time of a patient as it prevents the disease from going in to the severe stage.
The diagnosis can be carried out in intensive care units, operation room, and emergency room and operation theatres.
Asia Pacific is the region that is said to have the highest compounded annual growth. Also, the government reforms in countries like China and India has fuelled the growth of this industry. It is said to reach USD XX Billion by 2025.
Companies like Abbott Laboratories, Beckman-Coulter, Alere, Inc., and Roche Diagnostics are the key players of this industry. These companies are actively investing in the research of different tools so that they can come up with better solutions.

The global blood culture tests market by its major segments, which include as follows:

KEY BENEFITS OF THE REPORT:

Understanding of the strategies that are being adopted by the key players in this market to stay competitive
Extensive analysis of the key players dominating the competitive landscape of this market
In-depth analysis of the key factors are propelling the growth of the global market
Detailed analysis of the geographic region that will witness the strongest growth
Granular analysis of the current market scenario and the expected market grow

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY TYPE